Wikisage, the free encyclopedia of the second generation, is digital heritage
Levetiracetam: Difference between revisions
Jump to navigation
Jump to search
(/* Links *2nd/) |
(→Links: /) |
||
| Line 3: | Line 3: | ||
Trinka E., et al 2015 | Trinka E., et al 2015 | ||
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559580/pdf/40265_2015_Article_454.pdf Pharmacotherapy for Status Epilepticus] Drugs 75:1499 | *[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559580/pdf/40265_2015_Article_454.pdf Pharmacotherapy for Status Epilepticus] Drugs 75:1499 | ||
Safraski J.-P.2015 | |||
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519029/pdf/i1535-7511-15-2-94.pdf Is There Equipoise Between Phenytoin and Levetiracetam for Seizure Prevention in Traumatic Brain Injury?] | *[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519029/pdf/i1535-7511-15-2-94.pdf Is There Equipoise Between Phenytoin and Levetiracetam for Seizure Prevention in Traumatic Brain Injury?] | ||
Revision as of 02:58, 12 September 2015
(S)-2-(2-Oxopyrrolidin-1-yl)butanamide is an anticonvulsant medication used to treat epilepsy. It is the S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam
Links
Trinka E., et al 2015
- Pharmacotherapy for Status Epilepticus Drugs 75:1499
Safraski J.-P.2015